Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Hansa Biopharma Total Assets (Quarterly) : 122.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 122.00M |
| December 31, 2025 | 126.56M |
| September 30, 2025 | 78.80M |
| June 30, 2025 | 87.85M |
| March 31, 2025 | 70.03M |
| December 31, 2024 | 72.46M |
| September 30, 2024 | 92.80M |
| June 30, 2024 | 97.20M |
| March 31, 2024 | 77.68M |
| December 31, 2023 | 101.02M |
| September 30, 2023 | 107.79M |
| June 30, 2023 | 126.14M |
| March 31, 2023 | 144.62M |
| December 31, 2022 | 161.95M |
| September 30, 2022 | 124.44M |
| June 30, 2022 | 76.60M |
| March 31, 2022 | 95.45M |
| December 31, 2021 | 111.86M |
| September 30, 2021 | 124.85M |
| June 30, 2021 | 142.45M |
| March 31, 2021 | 150.38M |
| December 31, 2020 | 174.67M |
| September 30, 2020 | 170.55M |
| Date | Value |
|---|---|
| June 30, 2020 | 49.35M |
| March 31, 2020 | 54.45M |
| December 31, 2019 | 70.96M |
| September 30, 2019 | 74.79M |
| June 30, 2019 | 88.14M |
| March 31, 2019 | 96.82M |
| December 31, 2018 | 106.57M |
| September 30, 2018 | 64.09M |
| June 30, 2018 | 67.50M |
| March 31, 2018 | 77.31M |
| December 31, 2017 | 83.10M |
| September 30, 2017 | 23.88M |
| June 30, 2017 | 27.13M |
| March 31, 2017 | 29.81M |
| December 31, 2016 | 34.20M |
| September 30, 2016 | 18.53M |
| June 30, 2016 | 21.39M |
| March 31, 2016 | 25.16M |
| December 31, 2015 | 26.58M |
| September 30, 2015 | 28.61M |
| June 30, 2015 | 30.93M |
| March 31, 2015 | 6.326M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioArctic AB | 281.25M |
| Swedish Orphan Biovitrum AB | 8.530B |
| Diamyd Medical AB | 28.11M |
| BONESUPPORT HOLDING AB | 117.45M |
| BioInvent International AB | 56.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 150.89M |
| Shareholders Equity (Quarterly) | -28.90M |
| Debt to Equity Ratio | -4.150 |
| Current Ratio | 3.630 |
| Net Debt Paydown Yield | -1.54% |